Communication

Actualités

HEPHAISTOS-Pharma secures a €2 million seed round

25 janvier 2024
Actualités

HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer, today announced that it has raised a €2 million seed round to finance GMP transfer and advance its lead candidate towards the clinic. The round was co-led by xista science ventures and the Foundation Fournier-Majoie, with the participation of Noshaq. To know more